Space Lintec develops space-based pharmaceutical production using microgravity environments to produce more homogeneous drug proteins. The company operates a drop tower in a vertical mine shaft in Jeongseon, Gangwon to simulate microgravity on Earth and is constructing a longer drop tower at Taebaek’s Jangseong mine. CEO Yoon Hak‑soon has conducted space medicine research with NASA and Harvard Medical School, and the firm plans a suborbital satellite demonstration this year and a low‑Earth‑orbit demonstration in 2025. Space Lintec aims to reduce drug development cost and timelines by exploiting microgravity advantages. The company was founded in 2021 and has been selected for South Korean government programs including the ‘초격차 스타트업 1000+’ project and the Deep Tech TIPS program. Its current focus includes opening a joint space medicine research institute with Harvard Medical School.

Total raised

$3M

Funding rounds

1

Latest round

Series A

Latest activity

Apr 2024